Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.53 USD | +0.67% | +0.22% | -19.39% |
Mar. 15 | Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023. | CI |
Mar. 13 | Craig-Hallum Downgrades Champions Oncology to Hold From Buy | MT |
Financials (USD)
Sales 2024 * | 48.84M | Sales 2025 * | 53.68M | Capitalization | 61.58M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 1.26 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.15 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 73.79% |
Latest transcript on Champions Oncology, Inc.
1 day | +0.67% | ||
1 week | +0.22% | ||
1 month | -6.79% | ||
3 months | -18.82% | ||
6 months | -14.53% | ||
Current year | -19.39% |
Managers | Title | Age | Since |
---|---|---|---|
Ronnie Morris
CEO | Chief Executive Officer | 58 | 10-10-25 |
Brady Davis
PSD | President | - | 23-10-16 |
Joel Ackerman
CHM | Chairman | 59 | 10-10-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Sidransky
FOU | Founder | 64 | 07-12-31 |
Scott Tobin
BRD | Director/Board Member | 53 | 11-06-26 |
Joel Ackerman
CHM | Chairman | 59 | 10-10-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 4.53 | +0.67% | 1,414 |
24-05-30 | 4.5 | -2.39% | 921 |
24-05-29 | 4.61 | +0.88% | 2,240 |
24-05-28 | 4.57 | +1.11% | 4,222 |
24-05-24 | 4.52 | -2.38% | 3,640 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-19.39% | 61.58M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- CSBR Stock